Truist Financial’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Truist Financial’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,246	Closed	-$388K	–	873
2015 Q1	$388K	Sell	2,246 -257	-10%	-$37.7K	0.01%	580
2014 Q4	$288K	Sell	2,503 -92	-4%	-$11.1K	0.01%	648
2014 Q3	$406K	Sell	2,595 -800	-24%	-$116K	0.01%	543
2014 Q2	$419K	Sell	3,395 -643	-16%	-$71.1K	0.01%	548
2014 Q1	$419K	Sell	4,038 -2,603	-39%	-$267K	0.01%	548
2013 Q4	$597K	Sell	6,641 -1,509	-19%	-$120K	0.02%	460
2013 Q3	$545K	Buy	8,150 +485	+6%	+$33.4K	0.02%	471
2013 Q2	$507K	Buy	+7,665	New	+$438K	0.02%	471

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Truist Financial's SLXP Position: Q2 2015 in Review

Truist Financial sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,246 shares — an estimated $388K sold.

Truist Financial first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $597K in Q4 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Truist Financial reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Truist Financial sold 2,246 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $388K.
Truist Financial first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Truist Financial's SALIX PHARMACEUTICALS LTD DEL position peaked at $597K in Q4 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Truist Financial's 13F filing for Q2 2015, filed 29 Jul 2015.